» Articles » PMID: 26921370

Structural and Functional Abnormalities of the Neuromuscular Junction in the Trembler-J Homozygote Mouse Model of Congenital Hypomyelinating Neuropathy

Overview
Specialties Neurology
Pathology
Date 2016 Feb 28
PMID 26921370
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in peripheral myelin protein 22 (PMP22) result in the most common form of Charcot-Marie-Tooth (CMT) disease, CMT1A. This hereditary peripheral neuropathy is characterized by dysmyelination of peripheral nerves, reduced nerve conduction velocity, and muscle weakness. APMP22 point mutation in L16P (leucine 16 to proline) underlies a form of human CMT1A as well as the Trembler-J mouse model of CMT1A. Homozygote Trembler-J mice (Tr(J)) die early postnatally, fail to make peripheral myelin, and, therefore, are more similar to patients with congenital hypomyelinating neuropathy than those with CMT1A. Because recent studies of inherited neuropathies in humans and mice have demonstrated that dysfunction and degeneration of neuromuscular synapses or junctions (NMJs) often precede impairments in axonal conduction, we examined the structure and function of NMJs in Tr(J)mice. Although synapses appeared to be normally innervated even in end-stage Tr(J)mice, the growth and maturation of the NMJs were altered. In addition, the amplitudes of nerve-evoked muscle endplate potentials were reduced and there was transmission failure during sustained nerve stimulation. These results suggest that the severe congenital hypomyelinating neuropathy that characterizes Tr(J)mice results in structural and functional deficits of the developing NMJ.

Citing Articles

From in vivo models to in vitro bioengineered neuromuscular junctions for the study of Charcot-Marie-Tooth disease.

Scherrer C, Loret C, Vedrenne N, Buckley C, Lia A, Kermene V J Tissue Eng. 2025; 16:20417314241310508.

PMID: 40078221 PMC: 11898049. DOI: 10.1177/20417314241310508.


Neuromuscular monitoring of a patient with Charcot-Marie-Tooth disease; which monitoring technique is adequate? - A case report and literature review.

Kim S, Kim S, Jung K Anesth Pain Med (Seoul). 2024; 19(1):54-61.

PMID: 38311355 PMC: 10846999. DOI: 10.17085/apm.23111.


Implantable Electroceutical Approach Improves Myelination by Restoring Membrane Integrity in a Mouse Model of Peripheral Demyelinating Neuropathy.

Intisar A, Shin H, Kim W, Kang H, Kim M, Kim Y Adv Sci (Weinh). 2022; 9(32):e2201358.

PMID: 35975427 PMC: 9661852. DOI: 10.1002/advs.202201358.


Structure and Function of the Mammalian Neuromuscular Junction.

Davis L, Fogarty M, Brown A, Sieck G Compr Physiol. 2022; 12(4):3731-3766.

PMID: 35950651 PMC: 10461538. DOI: 10.1002/cphy.c210022.


Glycosylation limits forward trafficking of the tetraspan membrane protein PMP22.

Marinko J, Wright M, Schlebach J, Clowes K, Heintzman D, Plate L J Biol Chem. 2021; 296:100719.

PMID: 33933451 PMC: 8191293. DOI: 10.1016/j.jbc.2021.100719.


References
1.
Hahn J, Henry M, Hudgins L, Madan A . Congenital hypomyelination neuropathy in a newborn infant: unusual cause of diaphragmatic and vocal cord paralyses. Pediatrics. 2001; 108(5):E95. DOI: 10.1542/peds.108.5.e95. View

2.
Pun S, Sigrist M, Santos A, Ruegg M, Sanes J, Jessell T . An intrinsic distinction in neuromuscular junction assembly and maintenance in different skeletal muscles. Neuron. 2002; 34(3):357-70. DOI: 10.1016/s0896-6273(02)00670-0. View

3.
Tanaka Y, Hirokawa N . Mouse models of Charcot-Marie-Tooth disease. Trends Genet. 2002; 18(12):S39-44. DOI: 10.1016/s0168-9525(02)02839-1. View

4.
Suter U, Scherer S . Disease mechanisms in inherited neuropathies. Nat Rev Neurosci. 2003; 4(9):714-26. DOI: 10.1038/nrn1196. View

5.
Reddy L, Koirala S, Sugiura Y, Herrera A, Ko C . Glial cells maintain synaptic structure and function and promote development of the neuromuscular junction in vivo. Neuron. 2003; 40(3):563-80. DOI: 10.1016/s0896-6273(03)00682-2. View